Skip to main content

Table 2 Correlation between miR-143-3p expression and clinicopathological features

From: MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial–mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma

Patient characteristics MiR-143-3p expression X2 P value
Low (n = 54) High (n = 26)
Age    0.887 0.346
 Median 60     
 Range 38–74     
  < 60 34 21(38.9 %) 13(50 %)   
  ≥ 60 46 33(61.1 %) 13(50 %)   
Gender    3.242 0.072
 Female 18 9(16.7 %) 9(34.6 %)   
 Male 62 45(83.3 %) 17(65.4 %)   
Tumor location    0.608 0.738
 Upper 12 7(13 %) 5(19.2 %)   
 Middle 34 23(42.6 %) 11(42.3 %)   
 Lower 34 24(44.4 %) 10(38.5 %)   
Histological grade    0.547 0.761
 Poor 33 22(40.7 %) 11(42.3 %)   
 Moderate 31 20(37.0 %) 11(42.3 %)   
 Well 16 12(22.2 %) 4(15.4 %)   
pT status    1.6222 0.444
 pT1 12 10(18.5 %) 2(7.7 %)   
 pT2 25 16(29.6 %) 9(34.6 %)   
 pT3 43 28(20.2 %) 15(57.5 %)   
Lymph node metastasis    4.297 0.038*
 Absent (0) 33 18(33.3 %) 15(57.5 %)   
 Present (1/2/3) 47 36(66.7 %) 11(42.3 %)   
TNM stage    4.941 0.026*
 I/II 38 21(38.9 %) 17(65.4 %)   
 III 42 33(61.1 %) 9(34.6 %)   
  1. * p <0.05